Related references
Note: Only part of the references are listed.Inhibitory effect of sixteen pharmaceutical excipients on six major organic cation and anion uptake transporters
Ruicong Ma et al.
XENOBIOTICA (2021)
Natural products: potential treatments for cisplatin-induced nephrotoxicity
Chun-yan Fang et al.
ACTA PHARMACOLOGICA SINICA (2021)
Prospects of Wedelolactone as a Chemotherapeutic Agent in Gynecological Cancers; Clue From its In Vitro and In Silico Investigation
Sadia Sarwar et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2020)
Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2
Yunwen Yang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Myricitrin protects against cisplatin-induced kidney injury by eliminating excessive reactive oxygen species
Ruiqian Li et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2020)
Use of Amifostine for Cytoprotection during Radiation Therapy: A Review
Maurice King et al.
ONCOLOGY (2020)
Organic Cation Transporters in Health and Disease
Hermann Koepsell
PHARMACOLOGICAL REVIEWS (2020)
Potent Inhibitors of Organic Anion Transporters 1 and 3 From Natural Compounds and Their Protective Effect on Aristolochic Acid Nephropathy
Caiyu Li et al.
TOXICOLOGICAL SCIENCES (2020)
Isoorientin Attenuates Cisplatin-Induced Nephrotoxicity Through the Inhibition of Oxidative Stress and Apoptosis via Activating the SIRT1/SIRT6/Nrf-2 Pathway
Xiaoye Fan et al.
FRONTIERS IN PHARMACOLOGY (2020)
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection
Anna Hucke et al.
ARCHIVES OF TOXICOLOGY (2019)
Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway
Zhu Mao-mao et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity
Dong Guo et al.
PHARMACEUTICAL RESEARCH (2018)
Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges
Martina Perse et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-kappa B and improving mitochondrial function
Xiaowen Yu et al.
EBIOMEDICINE (2018)
Caspase-11 promotes cisplatin-induced renal tubular apoptosis through a caspase-3-dependent pathway
Naijun Miao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity
Daniel J. Crona et al.
ONCOLOGIST (2017)
Developing better mouse models to study cisplatin-induced kidney injury
Cierra N. Sharp et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride
L. P. Li et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Determination of Liposomal Cisplatin by High-Performance Liquid Chromatography and Its Application in Pharmacokinetic Studies
Alfonso Toro-Cordova et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2016)
Metformin Protects Against Cisplatin-Induced Tubular Cell Apoptosis and Acute Kidney Injury via AMPKα-regulated Autophagy Induction
Jianzhong Li et al.
SCIENTIFIC REPORTS (2016)
Transgenic Expression of the Human MRP2 Transporter Reduces Cisplatin Accumulation and Nephrotoxicity in Mrp2-Null Mice
Xia Wen et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs)
Qing Li et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events
Kazufumi Iwata et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Identification and evaluation of anti Hepatitis C virus phytochemicals from Eclipta alba
Dinesh Manvar et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
Sumito Ito et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Organic cation transporter OCT/SLC22A and H+/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents
Atsushi Yonezawa et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
Giuliano Ciarimboli et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity
Takanori Nakamura et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Protecting Cisplatin-Induced Nephrotoxicity with Cimetidine Does Not Affect Antitumor Activity
Hiromu Katsuda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
K. K. Filipski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Human and Murine Kidneys Show Gender- and Species-Specific Gene Expression Differences in Response to Injury
Han Si et al.
PLOS ONE (2009)
Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment
Lauren M. Aleksunes et al.
TOXICOLOGY (2008)
Structure-activity relationship of wedelolactone analogues:: Structural requirements for inhibition of Na+,K+-ATPase and binding to the central benzodiazepine receptor
Elisa S. C. Pocas et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
A human transporter protein that mediates the final excretion step for toxic organic cations
M Otsuka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels
AL Slitt et al.
DRUG METABOLISM AND DISPOSITION (2002)
Assessment of cisplatin-induced nephrotoxicity by microarray technology
Q Huang et al.
TOXICOLOGICAL SCIENCES (2001)
Share Paper
